{"id":"da93282e-f971-48ed-aa6a-0c795348314d","companyId":"dd249a2a-1d52-4dfd-8578-6d2cf51ad6a3","modelName":"RingConn (Gen 2 / Gen 3)","slug":"ringconn-gen2","description":"RingConn, a Shenzhen-based Chinese smart-ring maker, is the subscription-free anchor of the biometric ring market and a deliberate counterpoint to Oura and Whoop, recorded in the biometric form factor. Its Gen 2 ring sells for about $279 with a 10-to-12-day battery and a charging case extending to about 150 days, pairing PPG, skin-temperature, blood-oxygen, and accelerometer sensors with sleep, heart-rate, and a deep-learning sleep-apnea screening feature, and all standard features are free for life with no membership, the core positioning of the brand; the Gen 2 raised about $4.4 million on Kickstarter and the Gen 3 launched in late May 2026 with more than $10 million in pre-orders in about twenty days. Two corrections to common priors are load-bearing. First, RingConn's sleep-apnea and apnea-hypopnea-index feature is not FDA-cleared but wellness and pre-diagnostic: the company's own launch release says it is actively pursuing clearance and carries a not-intended-to-diagnose disclaimer, and the widely repeated claim that RingConn received FDA clearance for blood oxygen or sleep apnea appears only on aggregator sites and conflates it with the Happy Ring, the genuinely FDA-cleared sleep-apnea ring, so RingConn is recorded as not cleared with its 90.7-percent accuracy a vendor claim. Second, RingConn is not subject to an active US import ban: although it was a co-respondent found to infringe in Oura's International Trade Commission case over patent 11,868,178, it settled and Oura granted it a multi-year license to keep selling in the US, so only Ultrahuman's Ring Air carries the active ban. Its clinical-validation posture is wellness-grade and claim-heavy, and its founder identity, funding, and cumulative unit shipments are not reliably verified.","formFactor":"biometric","maturityStage":"commercial","lifecycleState":"active","supersededByModelId":null,"specs":{"notes":[{"label":"Verified (subscription-free anchor)","value":"RingConn (Shenzhen, China) is a smart-ring maker positioned as the SUBSCRIPTION-FREE counterpoint to Oura/Whoop - all standard features free for life (verified, consistent across primary + reviews). Gen 2 ~$279, 10-12 day battery; Gen 2 raised ~$4.4M on Kickstarter (category record); Gen 3 launched late May 2026 (>$10M in ~20 days of pre-orders). maturity=commercial / shipping at scale."},{"label":"CORRECTION (AHI NOT FDA-cleared - aggregator drift)","value":"RingConn's sleep-apnea / AHI feature is NOT FDA-cleared - it is wellness/'pre-diagnostic'. RingConn's own Gen 2 PR says it is 'actively pursuing FDA clearance' + carries a 'not intended to diagnose' disclaimer. The widely-repeated 'RingConn received FDA clearance for SpO2/sleep-apnea' claim appears ONLY on SEO/aggregator sites and CONFLATES RingConn with the Happy Ring (Happy Health, Austin - the genuinely FDA-cleared sleep-apnea ring). Recorded NOT cleared. The 90.7% accuracy is a vendor claim."},{"label":"CORRECTION (NOT banned - settled the ITC case)","value":"RingConn was a co-respondent in Oura's ITC case (337-TA-1398, Patent 11,868,178) and was found to infringe - BUT it SETTLED: Oura granted RingConn a multi-year patent LICENSE to keep selling in the US. So RingConn is NOT subject to an active import ban (US access = licensed/permitted). Only Ultrahuman's Ring Air carries the active ban."},{"label":"Verification posture / cap-flag","value":"Clinical posture: wellness-grade, claim-heavy (90.7% apnea accuracy + 'hundreds of clinical studies' are vendor-stated, no FDA clearance, no peer-review surfaced - lower than Oura/Happy). NOT verified: founder identity (aggregator-only, low confidence); funding (angel round aggregator-only; mostly crowdfunded); cumulative unit shipments (no reliable figure - don't attribute one)."}],"specs":"RingConn Gen 2 (~$279) + Gen 2 Air + Gen 3 (late May 2026). Sensors: PPG, skin temperature, SpO2, accelerometer. 10-12 day battery (charging case to ~150 days). AI/health: sleep + HR/HRV + 'sleep apnea / AHI' screening (deep-learning, claimed 90.7% accuracy). SUBSCRIPTION-FREE: all standard features free for life (the core positioning vs Oura/Whoop). Chinese (Shenzhen).","formFactor":"biometric (biometric-primary smart ring + AI augmentation; SUBSCRIPTION-FREE)"},"manufacturerSerial":null,"reviewStatus":"reviewed","sources":[{"url":"https://www.prnewswire.com/news-releases/ringconn-launches-gen-2-smart-ring-pioneering-sleep-apnea-detection-with-unmatched-10---12-days-battery-life-302212578.html","title":"RingConn Gen 2 (sleep-apnea feature 'actively pursuing FDA clearance'; 'not intended to diagnose')","sourceName":"RingConn (PR Newswire)"},{"url":"https://ouraring.com/blog/oura-itc-case/","title":"Oura ITC case (337-TA-1398, Patent 11,868,178): RingConn SETTLED -> multi-year license (not banned)","sourceName":"Oura (blog)"},{"url":"https://chinabizinsider.com/shenzhens-ringconn-challenges-oura-dominance-as-smart-ring-shipments-surge-49-at-ces-2026/","title":"RingConn = Shenzhen smart-ring maker; subscription-free; CES 2026","sourceName":"China Biz Insider"},{"url":"https://www.prnewswire.com/news-releases/ringconn-gen-3-smart-ring-officially-launches-302785564.html","title":"RingConn Gen 3 launches (late May 2026; >$10M in ~20 days of pre-orders)","sourceName":"RingConn (PR Newswire)"}],"aliases":["RingConn Gen 2","RingConn Gen 2 Air","RingConn Gen 3"],"collisionRisk":"low","reviewNote":null,"manufacturerTermForTeleop":null,"createdAt":"2026-06-03T22:45:50.947Z","updatedAt":"2026-06-03T22:45:50.947Z","jsonLd":{"@context":"https://schema.org","@type":"Product","@id":"https://registry.deploy.report/models/ringconn-gen2","url":"https://registry.deploy.report/models/ringconn-gen2","name":"RingConn (Gen 2 / Gen 3)","alternateName":["RingConn Gen 2","RingConn Gen 2 Air","RingConn Gen 3"],"description":"RingConn, a Shenzhen-based Chinese smart-ring maker, is the subscription-free anchor of the biometric ring market and a deliberate counterpoint to Oura and Whoop, recorded in the biometric form factor. Its Gen 2 ring sells for about $279 with a 10-to-12-day battery and a charging case extending to about 150 days, pairing PPG, skin-temperature, blood-oxygen, and accelerometer sensors with sleep, heart-rate, and a deep-learning sleep-apnea screening feature, and all standard features are free for life with no membership, the core positioning of the brand; the Gen 2 raised about $4.4 million on Kickstarter and the Gen 3 launched in late May 2026 with more than $10 million in pre-orders in about twenty days. Two corrections to common priors are load-bearing. First, RingConn's sleep-apnea and apnea-hypopnea-index feature is not FDA-cleared but wellness and pre-diagnostic: the company's own launch release says it is actively pursuing clearance and carries a not-intended-to-diagnose disclaimer, and the widely repeated claim that RingConn received FDA clearance for blood oxygen or sleep apnea appears only on aggregator sites and conflates it with the Happy Ring, the genuinely FDA-cleared sleep-apnea ring, so RingConn is recorded as not cleared with its 90.7-percent accuracy a vendor claim. Second, RingConn is not subject to an active US import ban: although it was a co-respondent found to infringe in Oura's International Trade Commission case over patent 11,868,178, it settled and Oura granted it a multi-year license to keep selling in the US, so only Ultrahuman's Ring Air carries the active ban. Its clinical-validation posture is wellness-grade and claim-heavy, and its founder identity, funding, and cumulative unit shipments are not reliably verified.","identifier":"da93282e-f971-48ed-aa6a-0c795348314d","category":"biometric","publisher":{"@id":"https://deploy.report/#organization"}}}